首页 › 超重 › 北卡罗来纳州 › Fayetteville
Fayetteville NC 超重临床试验
4项针对 超重的研究正在 Fayetteville及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Coastal Research Institute - Fayetteville, Fayetteville
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
招募中3 期
- Coastal Research Institute - Fayetteville, Fayetteville
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
招募中3 期欢迎健康志愿者
- ACCOMPLISH-2 Research Site, Fayetteville
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
招募中3 期
- ACCOMPLISH-1 Research Site, Fayetteville
其他城市的 超重试验
- San Antonio, TX34 项研究
- Houston, TX33 项研究
- Chicago, IL29 项研究
- Orlando, FL27 项研究
- Las Vegas, NV23 项研究
- Miami, FL23 项研究
- Dallas, TX20 项研究
- Atlanta, GA20 项研究
- New York City, NY19 项研究
- Jacksonville, FL19 项研究
- Washington, DC19 项研究
- Austin, TX18 项研究
Fayetteville的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。